FDA 510(k)

GlidePath 13F 长期血液透析导管

K号: K211410 · 2021-06-04

决定日期2021-06-04

产品代码MSD

咨询委员会GU 请注意，由于您只提供了“GU”这个词，我无法提供完整的翻译。如果您能提供完整的句子或段落，我将能够为您提供准确的翻译。

决定Unknown

器械摘要

GlidePath 13F Long-Term Hemodialysis Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2021-06-04 under 510(k) number K211410. The device is classified under product code MSD. It was reviewed by the GU advisory panel. FDA Decision: Unknown.

常见问题

What is the GlidePath 13F Long-Term Hemodialysis Catheter?

GlidePath 13F Long-Term Hemodialysis Catheter is a medical device that received FDA 510(k) clearance on 2021-06-04. The listed applicant is Bard Peripheral Vascular, Inc.. The 510(k) number is K211410.

When did GlidePath 13F Long-Term Hemodialysis Catheter receive FDA 510(k) clearance?

GlidePath 13F Long-Term Hemodialysis Catheter received FDA 510(k) clearance on 2021-06-04, under 510(k) number K211410.

Who is the listed applicant for GlidePath 13F Long-Term Hemodialysis Catheter?

FDA 510(k)记录将Bard Peripheral Vascular, Inc.列为申请人。这本身并不能确立该设备制造商的身份。

What is the FDA product code for GlidePath 13F Long-Term Hemodialysis Catheter?

The FDA product code for GlidePath 13F Long-Term Hemodialysis Catheter is MSD.

列明Bard Peripheral Vascular, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K262571EnCor EnCompass™乳腺活检和组织移除系统 K260012UltraScore™ 焦点力PTA球囊 K252681EnCor EnCompass™乳腺活检和组织移除系统 K250032Marquee® 一次性核心活检仪器和仪器套件 K250219Dorado™ PTA 扩张球囊导管 K243642UltraCor™ Twirl™ 乳腺组织标记器

查看所有 18 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。